“Meaningful Use” Antimicrobial Use and Resistance (AUR)

For 2018, NHSN Antimicrobial Use (AU) and Antimicrobial Resistance (AR) (AUR) reporting have been identified as a new option for public health registry reporting under Meaningful Use Stage 3 (MU3). This measure applies to Eligible Hospitals.

Beginning January 1, 2017, a facility enrolled in the National Healthcare Safety Network (NHSN) will be able to register their intent to satisfy the AUR-MU3 objective. The NHSN user interface will include an AUR-MU3 registration page and allow the NHSN Facility Administrator to register AUR-MU3 intent. Active engagement for this MU3 objective includes monthly electronic reporting for a full calendar year of R1 Normative Antimicrobial Use Summary, Antimicrobial Resistance Event, and Antimicrobial Resistance Summary data in the format of Clinical Document Architecture (CDA) to NHSN.

Hospitals report healthcare-associated infection (HAI) data to the Virginia Department of Health (VDH) via NHSN.  More information on NHSN reporting to VDH can be found here, and general information on healthcare-associated infections and antimicrobial resistance can be found here.


For questions, please contact the NHSN customer support desk at nhsncda@cdc.gov; please copy meaningfuluse@cdc.gov for tracking and follow-up.

Healthcare-Associated Infections and Antimicrobial Resistance Program:
(804) 864-8141


Page last modified: 6/27/2017 3:25PM